Publications
Implications of Pediatric Initiatives on CNS Drug Development for All Ages—2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
Gahan Pandina, Joan Busner, Joseph P. Horrigan, Christine McSherry, Alison Bateman-House, Luca Pani, Judith Kando
Innovations in Clinical Neuroscience, 2023;20(1-3): 18-24
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
Philip D. Harvey, Joan Busner, Gahan Pandina, H. Gerry Taylor, Meg Grabb, Joohi Jimenez-Shahed
Innovations in Clinical Neuroscience, 2023; 20(1-3): 13-17
Consistency Checks to Improve Measurement with the Hamilton Rating Scale for Anxiety (HAM-A)
Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, Ariana Anderson, Brianne Brown, Dong Jing Fu, Bashkim Kadriu, Alan Kott, Atul Mahableshwarkar, Jan Sedway, David Williamson, Christian Yavorsky, Nina R Schooler
Journal of Affective Disorders, Vol. 325
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials
Erica A. Smith, William P. Horan, Dominique Demolle, Peter Schueler, Dong-Jing Fu, Ariana E. Anderson, Joseph Geraci, Florence Butlen-Ducuing, Jasmine Link, Ni A. Khin, Robert Morlock, Larry D. Alphs
Innovations in Clinical Neuroscience, 2022;19(1–3):60-70.
Consistency Checks to Improve Measurement with the Hamilton Rating Scale for Depression (HAM-D)
Jonathan Rabinowitz, Janet B W Williams, Ariana Anderson, Dong Jing Fu, Nanco Hefting, Bashkim Kadriu, Alan Kott, Atul Mahableshwarkar, Jan Sedway, David Williamson, Christian Yavorsky, Nina R Schooler
Journal of Affective Disorders, Vol. 302, 1 April 2022
Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and Standardization
Joan Busner, Gahan Pandina, Silvia Zaragoza Domingo, Anna-Karin Berger, Maria T. Acosta, Nahome Fisseha, Joseph Horrigan, Jelena Ivkovic, William Jacobson, Dennis Revicki, and Victoria Villalta-Gil
Innovations in Clinical Neuroscience, 2021;18(10–12):15–22.
Opportunities and Challenges in Drug Development for ASD: Product of ISCTM/ECNP Joint Working Group
Celso Arango, Tiffany Farchione, Valentina Mantua, James C. McPartland, Geraldine Dawson, Gahan Pandina, Dragana Bugarski-Kirola, Ronald N Marcus
European Neuropsychopharmacology, Volume 48, July 2021 (Special Issue)
Drug Development for Autism Spectrum Disorder (ASD): Progress, Challenges, and Future Directions
James T. McCracken, Evdokia Anagnostou, Celso Arango, Geraldine Dawson, Tiffany Farchione, Valentina Mantua, James McPartland, Declan Murphy, Gahan Pandina, Jeremy Veenstra-VanderWeele, the ISCTM/ECNP ASD Working Group
European Neuropsychopharmacology, Volume 48, July 2021 (open access)
Diagnostic Criteria for Apathy in Neurocognitive Disorders
Krista L. Lanctôt, David S. Miller, Philippe Robert, Larry Ereshefsky, Lawrence Adler, Daniel Bateman, Jeff Cummings, Steven T. DeKosky, Corinne E. Fischer, Masud Husain, Zahinoor Ismail, Judith Jaeger, Alan J. Lerner, Abby Li, Constantine G. Lyketsos, Valeria Manera, Jacobo Mintzer, Hans J. Moebius, Moyra Mortby, Didier Meulien, Stephane Pollentier, Anton Porsteinsson, Jill Rasmussen, Paul B. Rosenberg, Myuri T. Ruthirakuhan, Mary Sano, Carla Zucchero Sarracini
Alzheimer's & Dementia, May 2021 (open access)
Consistency Checks to Improve Measurement with the Personal and Social Performance Scale (PSP)
Jonathan Rabinowitz, PhD, Mark Opler, MA, Alon A Rabinowitz, Selam Negash PhD, MSc, Ariana Anderson, PhD, Dong Jing Fu, MD, PhD, David Williamson, PhD, Alan Kott, MUDr, Lori L Davis, MD, Nina R Schooler, PhD
Schizophr Res . 2020 Nov 25;S0920-9964(20)30580-6. doi: 10.1016/j.schres.2020.11.040. (open access)